Kascoal indications
Topical/Cutaneous
Head pediculosis
Adult: A 4% solution is used for treatment.
Child: >6 mth: A 4% solution is used for treatment.
Topical/Cutaneous
As a skin protectant
Adult: As cream containing Kascoal 22% w/w and benzalkonium chloride 0.1% w/w. Apply to the affected area several times a day as needed.
Kascoal description
Kascoal contains dimethicone (silicone) 15%, cetyl alcohol (hexadecanol) 5% and glycerol 2%, in a lanolin-free cream base. It also contains methylhydroxybenzoate 0.2% and propylhydroxybenzoate 0.1% as preservatives. It has a pH of 6.
Kascoal does not contain perfume, lanolin or lanolin derivatives.
Kascoal dosage
Adults: Improvement of Abdominal Symptoms Due to Gas in the Gastrointestinal Tract: 120-240 mg daily divided into 3 times after or between meals by oral route.
Elimination of Foamy Mucus in the Stomach Prior to Gastric Endoscopy: 40-80 mg with about 10 mL of water at 15-40 min prior to the test by oral route.
Elimination of Gas in the Intestine Prior to Abdominal X-Ray Examination: 120-240 mg daily divided into 3 times after or between meals for 3-4 days prior to the test by oral route.
Some adjustments may be made according to the age and symptom of the patient.
Administration: Kascoal Drops: Shake and then use.
Kascoal interactions
Do not take this product if you are presently taking a prescription antibiotic drug of any form of tetracycline.
The rate and/or extent of absorption of many drugs may be increased or decreased when they are used concurrently with antacids.
Therefore, as a general rule, medication should not be taken within one to two hours of an antacid, if possible.
An incomplete list of substances for which the above statement has been shown to apply includes: tetracycline, iron sans, chlorpromazine, levodopa, isoniazid, digoxin, H2-antagonists, indomethacin, nitrofurantin, and dicumard.
An increase in the plasma level of quinidine and possible toxicity may result if alkalization of the urine occurs during antacid therapy.
Kascoal side effects
Adverse reactions were reported in 16 of 2546 patients (0.63%) treated with Kascoal. The most frequently observed adverse reactions were soft stools in 8 patients (0.31%), gastric discomfort in 4 patients (0.16%), diarrhea in 3 patients (0.12%) and stomachache in 3 patients (0.12%). No abnormal changes were reported in laboratory tests. (At the end of the re-evaluation.) See Table 2.
Kascoal contraindications
Tuberculous, viral lesions of the skin (e.g. herpes simplex and varicella); fungal lesions not susceptible to nystatin, facial rosacea, acne vulgaris or perioral dermatitis. Not to be applied to the external auditory canal in patients with perforated tympanic membranes. Do not use on extensive areas to reduce risk of systemic absorption and neomycin-induced ototoxicity. Not recommended for <1 yr.
Active ingredient matches for Kascoal:
Dimeticone in Taiwan.
| Unit description / dosage (Manufacturer) | Price, USD |
| Kascoal 40 mg x 100 x 10's | |
| Kascoal 40 mg x 1000's | |
| Kascoal 50 mg x 1000's | |
List of Kascoal substitutes (brand and generic names): | |
| Jacutin Pedicul Fluid (Germany) | |
| Kestomatine (Belgium, Luxembourg) | |
| Lice Clear (Malaysia) | |
| Lice Clear topical gel 70 mL x 1's (Apex) | |
| Linicin (United Kingdom) | |
| Loyon (Germany) | |
| Luxson (Taiwan) | |
| Luxson 40 mg x 100's | |
| Luxson 40 mg x 500's | |
| Luxson 40 mg x 1000's | |
| Mawei (Taiwan) | |
| Mawei 40 mg x 1000's | |
| Minifom (Finland, Iceland, Norway, Sweden) | |
| Capsule; Oral; Dimethicone 1000 188 mg; Silicon Dioxide Colloidal Anhydrous 12 mg (Astra) | |
| Drops; Oral; Dimethicone 1000 94 mg; Silicon Dioxide Colloidal Anhydrous 6 mg / ml (Astra) | |
| Neo Dimeticon (Brazil) | |
| Nopucid Focus (Argentina) | |
| NYDA (Canada, Turkey, United Kingdom) | |
| Nystal (Japan) | |
| Nystal 10% (Japan) | |
| Ophtasiloxane (France) | |
| Solution; Ophthalmic; Dimethicone 100% (Alcon) | |
| Piky (Portugal) | |
| Polygel (Taiwan) | |
| Polygel 15 mL | |
| Polysilan UPSA (Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Congo, Cote D'ivoire, France, Gabon, Guinea, Madagascar, Mali, Niger, Togo, Zaire) | |
| Polysilane (Oman) | |
| Gel; Oral; Aluminum Hydroxide; Simethicone (Clin midy) | |
| Polysilane 5 x 8's (Clin midy) | $ 3.48 |
| Polysilane 100 mL x 1's (Clin midy) | $ 2.11 |
| Polysilane 180 mL x 1's (Clin midy) | $ 3.48 |
| Polysilane / cap 60's (Clin midy) | $ 4.50 |
| Polysilane UPSA (France, Myanmar) | |
| Gel; Oral; Dimethicone 2.25 g | |
| Polysilo (Japan) | |
| Rosken Skin Repair (Australia, Singapore) | |
| Sab-Simplex (Austria, Bulgaria, Croatia (Hrvatska), Czech Republic, Estonia, Georgia, Germany, Hungary, Latvia, Lithuania, Romania, Russian Federation, Slovakia, Slovenia) | |
| Scarclinic (South Korea) | |
| Sen Sei (Colombia) | |
| Sensei (Chile) | |
| Setlers Floroflatine (Luxembourg) | |
| Sicaden (Austria) | |
| Silic 15 (Australia, Bahrain, Cyprus, Jordan, Kuwait, New Zealand, Saudi Arabia, United Arab Emirates, Yemen) | |
| Silic 15 75 g (Ego) | |
| Silic 15 75 g x 1's (Ego) | |
| Silic 15 500 g x 1's (Ego) | |
| Silic 15 200 g x 1's (Ego) | |
| Silic 15 500 g (Ego) | |
| Silic 15 cream 75 g x 1's (Ego) | |
| Silic 15 cream 500 g x 1's (Ego) | |
| Silicare (New Zealand) | |
| Capsule; Oral; Silicon / Silicon Dioxide 5 mg (Orion) | |
See 193 substitutes for Kascoal | |
Reviews
The results of a survey conducted on ndrugs.com for Kascoal are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Kascoal. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
2 consumers reported useful
Was the Kascoal drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 2 | 100.0% | |
2 consumers reported price estimates
Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?The below mentioned numbers have been reported by ndrugs.com website users about whether the Kascoal drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
| Users | % | ||
|---|---|---|---|
| Not expensive | 2 | 100.0% | |
9 consumers reported time for results
To what extent do I have to use Kascoal before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 1 week and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Kascoal. To get the time effectiveness of using Kascoal drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 1 week | 3 | 33.3% | |
| 2 weeks | 2 | 22.2% | |
| 2 days | 1 | 11.1% | |
| 1 month | 1 | 11.1% | |
| > 3 month | 1 | 11.1% | |
| 3 days | 1 | 11.1% | |
20 consumers reported age
| Users | % | ||
|---|---|---|---|
| > 60 | 7 | 35.0% | |
| 30-45 | 5 | 25.0% | |
| 16-29 | 3 | 15.0% | |
| < 1 | 2 | 10.0% | |
| 46-60 | 1 | 5.0% | |
| 1-5 | 1 | 5.0% | |
| 6-15 | 1 | 5.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
